NCT07325136
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07325136
Title A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination With Nivolumab in Participants With Relapsed/Refractory Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ROU | ITA | ESP

Facility Status City State Zip Country Details
Local Institution - 0011 NOT_YET_RECRUITING Detroit Michigan 48201 United States Details
Local Institution - 0026 NOT_YET_RECRUITING Buffalo New York 14263 United States Details
Local Institution - 0005 NOT_YET_RECRUITING Durham North Carolina 27710 United States Details
University Hospitals Cleveland Medical Center RECRUITING Cleveland Ohio 44106 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
Local Institution - 0001 NOT_YET_RECRUITING Rozzano Milano 20089 Italy Details
Local Institution - 0020 NOT_YET_RECRUITING Hirakata Osaka 573-1191 Japan Details
Local Institution - 0018 NOT_YET_RECRUITING Chuo-ku Tokyo 104-0045 Japan Details
Local Institution - 0023 NOT_YET_RECRUITING Timișoara Timiș County 300239 Romania Details
Local Institution - 0003 NOT_YET_RECRUITING Craiova 200347 Romania Details
Local Institution - 0009 NOT_YET_RECRUITING Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field